New Mesothelioma Publication by our REP Haining Yang: Molecular Determinants of Immunotherapy Efficacy in Mesothelioma: A Step Toward Precision Oncology
Read more here: https://www.jto.org/article/S1556-0864(25)01013-5/fulltext
New Publication by Dr. Testa and Dr. Kadariya: Spontaneous mesotheliomas in germline Bap1 heterozygous mice from different genetic backgrounds
Individuals carrying a germline BAP1 mutation are at increased risk of developing mesothelioma. In mice, there is limited information and controversy regarding whether germline Bap1
What is NMVB?
The National Mesothelioma Virtual Bank (NMVB) is the largest U.S. resource of mesothelioma biospecimens and de-identified clinical data, supporting research through a nationwide network of leading institutions. Explore our collection and request samples to advance mesothelioma discovery.
NMVB Network
The National Mesothelioma Virtual Bank is powered by the joint efforts of: